PSA Decrease with Fulvestrant Acetate in a Hormone-Resistant Metastatic Prostate Cancer Patient

Onkologie ◽  
2010 ◽  
Vol 33 (1-2) ◽  
pp. 57-59 ◽  
Author(s):  
Joan M. Gasent Blesa ◽  
Vicente Alberola Candel
Keyword(s):  
Prostate Cancer ◽  
Cancer Patient ◽  
Metastatic Prostate Cancer ◽  
Prostate Cancer Patient

Intratibial implantation of tumor cells  v1

2021 ◽  
Author(s):  
Shubhangi Agarwal ◽  
donna.peehl not provided ◽  
Renuka Sriram
Keyword(s):  
Prostate Cancer ◽  
Cancer Patient ◽  
Metastatic Prostate Cancer ◽  
Prostate Cancer Patient ◽  
Tumor Cell Line ◽  
Small Cell ◽  
Response To Therapy ◽  
Tumor Characteristics ◽  
Patient Derived Xenograft ◽  
Neuroendocrine Prostate Cancer

This protocol describes the steps required for the successful implantation of small cell neuroendocrine prostate cancer patient-derived xenograft (PDX) cells in the bone. Bone is one of the most common sites for the development of metastatic prostate cancer and its study is important for evaluating the tumor characteristics and response to therapy. This protocol can be used for the implantation of any tumor cell line in the bone.

Intrahepatic implantation of tumor cells v1

2021 ◽  
Author(s):  
Shubhangi Agarwal ◽  
Robert Bok ◽  
donna.peehl not provided ◽  
Renuka Sriram
Keyword(s):  
Prostate Cancer ◽  
Cancer Patient ◽  
Metastatic Prostate Cancer ◽  
Prostate Cancer Patient ◽  
Tumor Cell Line ◽  
Small Cell ◽  
Response To Therapy ◽  
Tumor Characteristics ◽  
Patient Derived Xenograft ◽  
Neuroendocrine Prostate Cancer

This protocol describes the steps required for successful implantation of small cell neuroendocrine prostate cancer patient-derived xenograft (PDX) cells in the liver. Liver is one of the most common sites for development of metastatic prostate cancer and its study is important for evaluating the tumor characteristics and response to therapy. This protocol can be used for implantation of any tumor cell line in the liver.

Sign in / Sign up

Export Citation Format

Share Document